Confronting TB/HIV in the Era of Drug Resistance
Author Information
Author(s): Chakaya Jeremiah, Getahun Haileyesus, Granich Reuben, Havlir Diane
Primary Institution: Centre for Respiratory Diseases Research, Kenya Medical Research Institute
Hypothesis
How can we effectively reduce the burden of tuberculosis (TB) in people living with HIV amidst increasing drug resistance?
Conclusion
The study emphasizes the urgent need for intensified TB screening and preventive therapy among people living with HIV to combat the intertwined epidemics of TB and HIV.
Supporting Evidence
- In 2006, less than 1% of HIV-infected persons were screened for TB.
- Only 0.1% of HIV-infected persons received Isoniazid Preventive Therapy in 2006.
- Countries like Rwanda and Botswana achieved high rates of TB testing among HIV patients.
Takeaway
Many people with HIV also have TB, and we need to do a better job of testing and treating them to save lives.
Limitations
The study highlights the low rates of TB screening and preventive therapy among HIV-infected individuals, indicating systemic issues in healthcare delivery.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website